This edited collection shows how the spread of HIV infection has been followed, represented, and managed in nine countries between 1982 and 1988. The countries cited in this study have been chosen to emphasize contrasts in the social and epidemiological profiles of AIDS, and to suggest the diversity of the problems constituted by HIV/AIDS in different national contexts. The juxtaposition of sequences of national response will raise questions about the range of policy options actually available to political and social policy-makers in a given context, and will invite further examination of the factors determining the acceptance or rejection of specific measures. Following the introduction, which outlines the choices that national governments confront in formulating AIDS policies, the successive chapters cover the reactions to HIV/AIDS in the United States, Brazil, France, Belgium, West Germany, Italy, Poland, Australia, and Africa. The final chapter compares the patterns of national response, identifies their common and divergent features, and points out tensions in policy-making caused by current changes in the spread of infection and in the understanding of the virus. This book makes informative reading for those who want to learn more about international variation in the political, social, and economic aspects of the AIDS epidemic.

Is There a Link between the Nature of Agents That Trigger Mast Cells and the Induction of Immunoglobulin (IG)E Synthesis?.- Immunogenetic Aspects of IgE-Mediated Responses.- Structure and Function of the Low Affinity IgE Receptor.- Characterization of the Human IgE Fc-Fce RIa Interaction.- The Analysis of Mast Cell Function in Vivo Using Mast Cell-Deficient Mice.- The Immunogenetic Basis of Collagen Induced Arthritis in Mice: An Experimental Model for the Rational Design of Immunomodulatory Treatments of Rheumatoid Arthritis.- Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance.- T Cell Reactivity to Self and Allogeneic MHC-Peptides.- Antiribosomal Antibodies in SLE, Infection, and Following Deliberate Immunization.- Cross-Reactions of Anti-Immunoglobulin Sera with Synthetic T-Cell Receptor ? Peptides: Mapping on a 3-Dimension Model.- Stress Proteins in Autoimmunity.- Polyclonal B Cell Activation and B Cell Cross-Reactivity During Autoantibody Production in Systemic Lupus Erythematosus.- Autoantibody Activity and V Gene Usage by B-Cell Malignancies.- Naturally Occurring Human Autoantibodies to Defend T-Cell Receptor and Light Chain Peptides.- Natural Autoantibodies.- Regulatory Autoantibody and Cellular Aging and Removal.- B-Cell Origin of Cold Agglutinins.- Initiation of Autoimmune Type 1 Diabetes and Molecular Cloning of a Gene Encoding for Islet Cell-Specific 37KD Autoantigen.- Mapping of the Polypeptide Chain Organization of the Main Extracellular Domain of the ?-Subunit in Membrane-Bound Acetylcholine Receptor by Anti-Peptide Antibodies Spanning the Entire Domain.

T-Cell/Macrophage Activation and HIV Infection.- 1. CD4+ and CD8+ T Lymphocyte Activation in HIV Infection: Implications for Immune Pathogenesis and Therapy.- 2. Markers of Immune Cell Activation and Disease Progression: Cell Activation in HIV Disease.- 3. The Role of the Cell Cycle in HIV-1 Infection.- 4. Molecular Basis of Cell Cycle Dependent HIV-1 Replication: Implications for Control of Virus Burden.- 5. Regulation of Macrophage Activation and HIV Replication.- 6. Investigations on Autologous T-Cells for Adoptive Immunotherapy of AIDS.- 7. Rational Problems Associated with the Development of Cellular Approaches in Controlling HIV Spread.- Apoptosis and Viropathogenesis of HIV Disease.- 8. The Role of Surface CD4 in HIV-Induced Apoptosis.- 9. Mechanism of Apoptosis in Peripheral Blood Mononuclear Cells of HIV-Infected Patients.- 10. Programmed Death of T Cells in the Course of HIV Infection.- 11. T Cell Apoptosis as a Consequence of Chronic Activation of the Immune System in HIV Infection.- 12. Apoptosis during HIV Infection: A Cytopathic Effect of HIV or an Important Host-Defense Mechanism against Viruses in General?.- Apoptosis and Immunopathogenesis of HIV Disease.- 13. From Cell Activation to Cell Depletion: The Programmed Cell Death Hypothesis of AIDS Pathogenesis.- 14. Immunosuppression by a Noncytolytic Virus Via T Cell Mediated Immunopathology: Implication for AIDS.- 15. Clonal Expansion of T Cells and HIV Genotypes in Microdissected Splenic White Pulps Indicates Viral Replication in Situ and Infiltration of HIV-Specific Cytotoxic T Lymphocytes.- 16. Autoimmunity, Apoptosis Defects, and Retroviruses.- 17. AIDS as Immune System Activation: Key Questions that Remain.- Mediators of T-Cell Activation/Apoptosis and Therapeutic Applications.- 18. Inhibition of T Lymphocyte Activation and Apoptotic Cell Death by Cyclosporin A and Tacrolimus (FK506): Its Relevance to Therapy of HIV Infection.- 19. Cyclophilin and Gag in HIV-1 Replication and Pathogenesis.- 20. Long-Term Follow-up of HIV Positive Asymptomatic Patients Having Received Cyclosporin A.- 21. Prospective Views of HIV Pathology: Clues for Therapeutic Strategies.

In this book, expert AIDS researchers critically review every aspect of this highly topical subject. HIV Chemotherapy examines the management of HIV infections and includes a fascinating review of current molecular strategies to protect and strengthen the host immune system at the cellular level. It also summarizes the strategies required for the implementation of effective anti-HIV therapies in developing countries (90% of worldwide AIDS cases). The book reviews the genetics of viral drug resistance, and current drug-resistance testing technologies. It also provides cutting-edge reviews of the latest viral and cellular targets for anti-HIV chemotherapy, the development of iRNA based therapeutics and molecular based strategies that target latent virus reservoirs in infected individuals.

HIV/AIDS continues to be the pandemic of our times. It is estimated that 36 to 45 million people including 2-3 million children already are infected worldwide and an additional 4-7 million more are infected each year.
There has not been a comprehensive medically based AIDS prevention book published in the last five years. Since that time many new program interventions have been tried and much has been learned through evidence-based research. HIV Prevention will place special focus on the array of interventions that have been proven effective through rigorous study. If there is one theme that has been learned to date it is that there is no one-size-fits-all prevention approach that will work in all the geographic, demographic and socio-cultural environments impacted by the worldwide AIDS pandemic.
* Discusses all aspects of AIDS prevention, from epidemiology, molecular immunology and virology to the principles of broad-based public health prevention interventions.
* Special focus on the array of interventions that have been proven effective through rigorous study
* Identifies new trends in HIV/AID epidemiology and their impact on creating and implementing prevention interventions
* Incorporates virology, biology, infectious diseases, vaccinology, microbicides and research methodologies into AIDS prevention

This book addresses the impact of HIV on populations of men who have sex with men in Africa and local responses to the issue. It documents the enduring existence of a rich variety of same-sex practices between men. More critically, it analyses how the denial and social rejection of same-sex sexuality, together with the legacy of criminalization by former colonial rulers, has not only fueled the transmission of HIV between men, but has also impeded an effective response. The book also documents some of the outstanding progress that has been made and acknowledges the differences between African countries. Through its focus on lived realities and grassroots activism in Africa, this book will appeal to researchers, policy makers and practitioners alike.

"HIV alters the lives of anyone that it touches, whether they are gay or straight. This book looks at all of the aspects of how HIV/AIDS has altered the lives of those it touches. . . . The titles of the 12 chapters give an excellent overview of what is covered in these extremely well-written reports. . . . This is a must-read book for everyone. It should be in all libraries, including school libraries. Young adolescents who are facing the problem of coming out would benefit from this book." --AIDS Book Review Journal Hit hard by the AIDS epidemic in the United States and in much of Europe, the gay and lesbian community has been forced to examine existing notions of what it means to belong to a community based on sexual orientation. The editors of this second volume in the annual series Psychological Perspectives on Lesbian and Gay Issues have collected a perceptive array of chapters that explore sexual behavior, personal identity, and community memberships of gay men and lesbian women. With the exception of a few, the chapters reflect study findings from AIDS-related research and include discussions of AIDS in large urban centers and in less populated settings outside of major AIDS epicenters. Focusing on underconsidered AIDS populations, the contributors explore specific topics concerning the AIDS epidemic among gay and bisexual men of color, lesbian women, and gay and lesbian youth. Accessible and sensitive, the book also examines relevant public policy, volunteerism, and long-term survival as important to AIDS awareness and education. AIDS, Identity, and Community is an appreciable resource for AIDS researchers and caregivers, mental health practitioners, social service professionals, behavioral and social science students, and any reader who seeks deeper insight into the complex and subtle areas of the lesbian and gay community in the AIDS era.

A moving collection of firsthand accounts of the HIV epidemic. Tremendous strides have been made in the prevention and treatment of HIV since the disease first appeared in the 1980s. But because many of the people who studied and battled the virus in those early days are now gone, firsthand accounts are at risk of being lost. In HIV Pioneers, Wendee M. Wechsberg collects 29 "first stories" from the outset of the AIDS epidemic. These moving personal narratives and critical historical essays not only shed light on the experiences of global health pioneers, prominent scientists, and HIV survivors, but also preserve valuable lessons for managing the risk and impact of future epidemics. With unprecedented access to many key actors in the fight against AIDS and HIV, Wechsberg brings to life the harrowing reality of those early days of the epidemic. The book captures the experiences of those still working diligently and innovatively in the field, elevating the voices of doctors, scientists, and government bureaucrats alongside those of survivors and their loved ones. Focusing on the impact that the epidemic had on careers, pieces also show how governments responded to HIV, how research agendas were developed, and how AIDS service agencies and case management evolved. Illuminating the multiple facets of the HIV epidemic, both in the United States and across the globe, HIV Pioneers is a touching and inspirational look into the ongoing fight against HIV. Contributors: Quarraisha Abdool Karim, Salim S. Abdool Karim, Lynda Arnold, Anne Jeanene Bengoa, Robert E. Booth, Barry S. Brown, Thomas Coates, Francine Cournos, James W. Curran, Don C. Des Jarlais, Jeffrey D. Fisher, William A. Fisher, Samuel R. Friedman, Robert C. Gallo, Mary Guinan, Gibbie Harris, Warren W. Hewitt Jr., Susan M. Kegeles, Rayford Kytle, Bishop Stacey S. Latimer, Robert Love, Duane C. McBride, Clyde B. McCoy, Carmen Morris, Willo Pequegnat, Mary Jane Rotheram-Borus, Jeffrey Samet, David Serwadda, Lorraine Sherr, James L. Sorensen, Jack B. Stein, Charles van der Horst, Wendee M. Wechsberg, Wayne Wiebel, William A. Zule

Although it is one of the most-widely studied viruses, many mysteries still remain about HIV. Covering the latest advances and challenges associated with clinical application of new antiviral drugs and vaccines, this revised edition is a companion to Murad: "HIV-1: Molecular Biology and Pathogenesis, 2E." Leading investigators in HIV research present a timely picture of the molecular mechanisms which guide HIV-1 expression and replication and provide the most current clinical strategies for combating this virus.
* The latest developments in HIV-vaccine research
* New concepts in the discovery and design of novel anti-HIV drugs

The major purpose of this book is to examine the interrelationships among knowledge about the transmission of HIV/AIDS, condom use, drug use, history of sexually transmitted diseases, and other relevant factors that affect African-American males and females who engage in risky sexual behaviors. Another aim is to describe how these factors are differentially related to gender and the perceived susceptibility of being exposed to the AIDS virus and testing positive for AIDS. Data has been gathered from a young adult sample of African-American males and females. Information is presented in a readily accessible manner so the reader can understand the variability of risky sexual behaviors. The author offers factual information to draw conclusions that can be used to develop HIV/AIDS prevention programs specifically tailored for the African-American community.

The first chapter provides an introduction, rationale, and overview of the study. Basic information about the prevalence of AIDS among various African-American populations are presented. Then, Johnson describes information about the subjects, measures of sexual behaviors, drug use, attitudes about the use of condoms, knowledge about AIDS, and perceived susceptibility of being exposed to HIV/AIDS. Next, Johnson describes the sexual attitudes and behaviors of African-American males and females who are currently involved with multiple partners and those who have been previously treated for sexually transmitted diseases. He then describes the characteristics of African-Americans with HIV/AIDS. The epilogue summarizes the major findings and presents suggestions for AIDS prevention activities for African-American young adults.

While HIV spreads among people with severe mental illness for the same reasons it does in the general population, there are specific ways in which mental illness is associated with elevated HIV risk. Every mental health institution or program has to deal with the consequences of increased HIV rates, but until now there has been no single book that could tell them how to do so. AIDS and People with Severe Mental Illness covers the entire range of information essential for those who work with these patients: epidemiological, medical, psychological, legal, ethical, and policy issues are all examined by eminent authorities in those areas. Nurses, social workers, psychologists, psychiatrists, mental health administrators, forensic specialists, and others involved in the care of people with severe mental illness will find here exactly what they have been looking for: one handbook that can help them deal with the challenges the AIDS epidemic has set before them.

This volume provides a comprehensive understanding of HIV/AIDS and neuro-AIDS, including a history of the disease, and an explanation of many of the conditions that can arise in afflicted patients, including opportunistic infections, central nervous system tumors, spinal cord disorders, myopathies and progressive encephalopathy, amongst others.

Clinicians will gain a greater understanding of the complex mechanisms of the disease. Beginning with a basic introduction to HIV infections and Neuro-AIDS, practitioners will find useful data on advances in molecular biology, neuroepidemiology, neuroimaging, neuropathology, neuropharmacology, as well as information on the development of therapeutic strategies appropriate for the disorder, including groundbreaking retroviral therapies.

In addition, the socioeconomic and political constraints that hinder treatment and disease management in developing parts of the world are presented.
* A comprehensive understanding of HIV/AIDS and neuro-AIDS, and the progression of the scientific community s understanding of the disease
* Detailed information on fields such as neuroepidemiology, neuropathology, neuropharmacology, and neuroimaging and their contributions to HIV/AIDS research
* Subject specific chapters on conditions associated with HIV/AIDS, including opportunistic infections, central nervous system tumors, and myopathies, amongst others"

The association between AIDS and cancer was recognized from the beginning of the AIDS epidemic, when the appearance of Kaposi sarcoma in a cluster of young men was one of the first signs of this new disease. It was soon recognized that AIDS was caused by infection with a novel virus (HIV) and that AIDS patients are prone to develop a number of "AIDS-defining" cancers: Kaposi sarcoma, lymphoma, and cervical cancer. The development of effective combination anti-HIV therapy starting around 1996 converted AIDS from a death sentence to a manageable disease and led to dramatic shifts in the epidemic. As this therapy was able to improve immune function in patients, the incidence of most "AIDS-defining" cancers decreased. There is a misconception, however, that AIDS has gone away. In fact, as AIDS patients are living longer, the number of AIDS patients has more than doubled in the United States since 1996, and the AIDS population overall has increased in age. Also, as AIDS patients are less likely to die of other complications, cancer is coming to the forefront as one of the most common causes of death in regions where AIDS drugs are widely available. Moreover, the three "AIDS-defining" cancers are now taking a back seat to a number of other HIV-associated cancers, such as Hodgkin lymphoma, lung cancer, and anal cancer. In the developing world, AIDS-associated cancers are a major public health problem, and in some regions of sub-Saharan Africa, Kaposi sarcoma is the most common tumor in men. In recent years, there has been a vast increase in our understanding of HIV-associated cancers. We now know, for example, that most are caused by other viruses and that the main role of HIV and immunodeficiency is to provide a supportive environment for the viruses to multiply and for the cancers to develop. But there remain a number of unanswered questions and a need for improved prevention and therapy. In the 28 chapters of this book, written by some of the most renowned experts in this field, we present up-to-date information on the cancers associated with HIV infection. The chapters cover the epidemiology of these cancers, their pathogenesis, their clinical presentation, and their treatment. The book will be of value to physicians, other medical professionals, students, and researchers with an interest in AIDS, viral-associated cancers, or HIV-associated malignancies. TABLE OF CONTENTS 1. HIV-associated Cancers: Overview Robert Yarchoan, Thomas Uldrick, Mark Polizotto 2. Epidemiology of AIDS-defining Malignancies William A. Blattner and Rebecca G. Nowak 3. Epidemiology of non-AIDS Defining Malignancies Andrew E. Grulich 4. HIV Cancers in Resource-Limited Regions Sam M. Mbulaiteye 5. Kaposi's Sarcoma-associated Herpesvirus (KSHV) Blossom Damania and Dirk P. Dittmer 6. Epstein Barr Virus (EBV) Lindsey Hutt-Fletcher 7. Human Papillomavirus (HPV) Zhi-Ming Zheng 8. Merkel Cell Polymavirus (MCV) Nicole Fischer and Adam Grundhoff 9. Presentation and Pathogenesis of Kaposi's Sarcoma Corey Casper 10. Management of Kaposi's Sarcoma Susan E. Krown 11. Presentation and Pathogenesis of HIV Lymphomas Richard F. Little, Stefania Pittaluga, Kieron Dunleavy 12. Diffuse Large B-Cell Lymphoma Neel K. Gupta and Lawrence D. Kaplan 13. Burkitt and Burkitt-Like Lymphoma Kishor Bhatia and Sam M. Mbulaiteye 14. Primary Effusion Lymphoma Giovanna Tosato 15. AIDS-related Central Nervous System Lymphoma Jan Davidson-Moncada and Thomas Uldrick 16. Plasmablastic and Other Lymphomas Huan-You Wang, Ida Wong-Sefidan, Erin Reid 17. Hodkin Lymphoma Michele Spina, Rosanna Ciancia, Accursio Augello 18. Multicentric Castelman Disease Mark N. Polizzotto, Thomas S. Uldrick, Robert Yarchoan 19. Cervical Cancer Elizabeth A. Stier 20. Anal Cancer Joel Palefsky 21. Other HPV-Associated Cancers Kristina R. Dahlstrom and Erich M. Sturgis 22. Lung Cancer in HIV Infection Deepthi Mani and David M. Aboulafia 23. Hepattocellular Carcinoma in HIV-positive Patients Massimiliano Berretta, Paolo De Paoli, Umberto Tirelli, Bruno Cacopardo 24. Merkel Cell Carcinoma and Other HIV-associated Skin Cancers Nathalie C. Zeitouni adn Bethany Lema 25. Conjuctival Carcinoma Kenneth O. Simbiri and Erle S. Robertson 26. Malignancies in Children with HIV Infection D. Cristina Stefan 27. cART and Supportive Care Ronald T. Mitsuyasu 28. Stem Cell Transplantation Christine Durand and Richard Ambinder

In June 1981, the Centers for Disease Control and Prevention reported the first evidence of a new disease that would later become known as Acquired Immunodeficiency Syndrome (AIDS). HIV and Aids: Basic Elements and Priorities is a concise collection of all aspects of this disease and a source of readily available knowledge. It examines all currently advocated preventive measures such as health education, condom use, safer sex practices, and treatment of sexually transmitted infections. Coverage includes: up-to-date information on multiple dimensions of the HIV/AIDS epidemic; a discussion on new anti-retroviral therapy/drugs, new drugs under clinical trials and preventive HIV vaccine; coverage of current ethical, legal and social issues related to HIV/AIDS; an evaluation of general public awareness about HIV/AIDS; a global perspective and information about HIV/AIDS.

The study of viruses necessarily involves dissecting the intimate details of cellular pathways. Viruses have often been employed as tools in studying cellular pathways, as was done by early retrovirologists such as Peyton Rous in attempting to understand the mechanism of cellular transformation and oncogenesis. On the other side of the coin, virologists seek to de?ne those cellular elements interacting intimatelywiththeir virus ofinterestinorder to better understand viral replication itself, and in some cases to develop antiviral strategies. It is in the intersection of virology and cell biology that many of us ?nd the most rewarding aspects of our research. When a new discovery yields insights into basic cellular mechanisms and presents new targets for int- vention to ?ght a serious pathogen, the impact can be high and the excitement intense. HIV has been no exception to the rule that viruses reveal many basic aspects of cellular biology. In recent years, in part because of the importance of HIV as a major cause of human suffering, numerous cellular processes have been elucidated through work on processes or proteins of this human retrovirus. The excitement in this ?eld is especially well illustrated by the discovery of new innate means of resisting viral replication, such as the work on APOBEC3G, TRIM5a, and BST-2/ tetherin presented in this volume.

Entry Inhibitors in HIV Therapy details the current status of this relatively new and very dynamic class of inhibitors, appealing to both the clinician and basic research scientist. A unique overview of obstacles and accomplishments is presented. The book features chapters that explain the challenges of high sequence diversity in the viral envelope gene for the development and use of entry inhibitors, the clinical utility of virus phenotyping, the development of this class of inhibitors as microbicidal therapy, and the success story of enfuvirtide from the bench to FDA approval. Both basic research findings and results of clinical studies are covered and linked together by a diverse panel of experts in the field.

This wide-ranging volume reviews the experience and treatment of HIV/AIDS in rural America at the clinical, care system, community, and individual levels. Rural HIV-related phenomena are explored within healthcare contexts (physician shortages, treatment disparities) and the social environment (stigma, the opioid epidemic), and contrasted with urban frames of reference. Contributors present latest findings on HIV medications, best practices, and innovative opportunities for improving care and care settings, plus invaluable first-person perspective on the intersectionality of patient subpopulations. These chapters offer both seasoned and training practitioners a thorough grounding in the unique challenges of providing appropriate and effective services in the region. Featured topics include: Case study: Georgia's rural vs. non-rural populations HIV medications: how they work and why they fail Pediatric/adolescent HIV: legal and ethical issues Our experience: HIV-positive African-American women in the Deep South Learning to age successfully with HIV Bringing important detail to an often-marginalized population, HIV/AIDS in Rural Communities will interest and inspire healthcare practitioners including physicians, nurse practitioners, physician assistants, pharmacists, case managers, psychologists, social workers, counselors, and family therapists, as well as educators, students, persons living with HIV, advocates, community leaders, and policymakers.

The development of proteomic analyses using advanced mass spectrometry techniques has revolutionized the way proteins are studied, namely, as individual molecules within a complex system. HIV-1 Proteomics: From Discovery to Clinical Application comprehensively covers protein analysis from the early classic experimental days to current state-of-the-art HIV-1 proteomics in a clear informative style that brings expert-level understanding to the novice. Discussion of important clinical applications and future directions for the field also make this an ideal read for the expert. After finishing this book, the reader will have a complete and functional understanding of protein analysis from traditional biochemistry to modern proteomics.

Asia has become the new battle ground for the war against HIV/AIDS. The magnitude of the potential public health problems caused by AIDS in this populous continent may become a catastrophic disaster. A 10% rate of prevalence of HIV-1 in India and China alone would mean more than 200 million people are infected with HIV.
AIDS in Asia is useful as a comprehensive, up-to-date AIDS reference book for public health and medical professionals. This volume provides concrete information on the diagnosis, treatment, care, prevention and impact of AIDS. Part I contains 'Snapshots of HIV/AIDS in Asia.' Countries and regions included in this section are: Thailand, India, China, Japan, Vietnam, Laos, Cambodia, Myanmar, Malaysia, Indonesia, the Philippines, Pakistan, Nepal, Sri Lanka, Hawaii and the Pacific Islands, Hong Kong and Taiwan. Part II addresses the molecular epidemiology of HIV/AIDS. Part III deals with the diagnosis, surveillance and projected scenarios of the AIDS epidemic. Part IV outlines prevention efforts and treatment options. Part V provides an overview of the ongoing collaborative efforts involved in several different nations in the worldwide war against AIDS.
This volume will be invaluable to all the public health professionals and researchers working in this field.

..".the book is a useful addition to the HIV/AIDS literature."

"AIDS in Asia offers a comprehensive, interesting overview of the epidemic there and of general issues that will influence its progression."

-Roger Detels, MD, MS, University of California-Los Angeles

The Journal of the American Medical Association, Book Review, 293:15